R-306465

DB12382InvestigationalSmall molecule

R306465 has been used in trials studying the treatment of Neoplasms.

Chemical structure of R-306465
Mechanism
Curator reviewed
Formula / weight
C19H19N5O4S · 413.45 g/mol (avg)
Code names
JNJ-16241199 · R306465

Resolves to

Compound
UNII5WD7KK1IIQCAS604769-01-9ChEMBLCHEMBL609583PubChem10309899
Structure
InChIKeyMUTBJZVSRNUIHA-UHFFFAOYSA-NSMILESONC(=O)C1=CN=C(N=C1)N1CCN(CC1)S(=O)(=O)C1=CC2=CC=CC=C2C=C1
Targets
Q9BY41HDAC8Q13547HDAC1

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
40Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with R-306465, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In